Policy Forum Members
For-profit Organizations
- Abbott Vascular International BVBA
- AMGEN (Europe) GmbH
- AstraZeneca (UK) Ltd
- Boehringer Ingelheim
- Boston Scientific Corporation
- Bristol-Myers Squibb
- Edwards Lifesciences
- Eli Lilly and Company
- F. Hoffmann-La Roche AG
- GlaxoSmithKline
- Johnson & Johnson
- Medtronic
- Merck & Co
- Merck KGaA
- Novartis Pharma AG
- Pfizer Limited
- Sanofi Genzyme
- W. L. Gore & Associates
Not-for-profit organizations
- BCBSA – Blue Cross Blue Shield Association (USA)
- CADTH – Canadian Agency for Drugs and Technologies in Health (Canada)
- CONITEC – National Committee for Technology Incorporation (Brazil)
- HASĀ – French National Authority for Health (France)
- Healthcare Improvement Scotland (UK)
- HTAA – Health Technology Assessment Association (Russia)
- ICER – Institute for Clinical & Economic Review (USA)
- IQWiG – Institute for Quality and Efficiency in Health Care (Germany)
- Kaiser Permanente (USA)
- NECA – National Evidence-based Healthcare Collaborating Agency (South Korea)
- NICE – National Institute for Health and Care Excellence (UK)
- NIPHNO – Norwegian Institute of Public Health Norway (Norway)
- PBAC & MSAC Australia Government, Department of Health and Ageing (Australia)
- PCORI – Patient-Centered Outcomes Research Institute (USA)
- Swedish Council on HTA (SBU) and Swedish Dental and Pharmaceutical Benefits Agency (TLV) – joint membership (Sweden)
- ZINL – National Health Care Institute (Netherlands)
- AQuaS – Agency of Health Quality and Assessment of Catal
- onia (Spain)
- BC Cancer (Canada)
- IETS – Institute of Technological Evaluation in Health (Colombia)
- AGENAS – Agenzia Nazionale per i Servizi Sanitari Regionali